{"title":"A critical review of technical progress, clinical heterogeneity, and implementation challenges of artificial intelligence in digestive endoscopy.","authors":"Eyad Gadour, Bodour Raheem, Antonio Facciorusso","doi":"10.1080/17474124.2026.2646299","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Digestive endoscopy is a critical modality for diagnosing and managing gastrointestinal diseases, yet it faces challenges including operator dependence, procedural complexity, and potential complications. Artificial intelligence (AI) has emerged as a promising adjunct to address these limitations by enhancing diagnostic accuracy and optimizing procedural workflows.</p><p><strong>Areas covered: </strong>This review comprehensively examines the application of AI across diverse clinical practices in digestive endoscopy. Key areas include lesion detection and diagnosis, lesion characterization and classification, quality control, workflow optimization, and therapeutic guidance. Additionally, it highlights the principal AI technologies that have received regulatory approval from the Food and Drug Administration (FDA) and European CE marking, underscoring their clinical readiness and integration potential.</p><p><strong>Expert opinion: </strong>AI demonstrates significant potential to improve endoscopic outcomes by augmenting lesion detection rates and diagnostic precision. However, the translation of AI innovations into routine clinical practice is tempered by challenges, such as variability in clinical effectiveness, dependency on procedural quality, domain generalizability, and cost-effectiveness considerations. Future advancements should focus on enhancing AI robustness, integrating multimodal data, and establishing sustainable implementation frameworks to maximize clinical benefit while maintaining patient safety and ethical standards.</p>","PeriodicalId":12257,"journal":{"name":"Expert Review of Gastroenterology & Hepatology","volume":" ","pages":"335-351"},"PeriodicalIF":2.5000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Gastroenterology & Hepatology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/17474124.2026.2646299","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/3/23 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Digestive endoscopy is a critical modality for diagnosing and managing gastrointestinal diseases, yet it faces challenges including operator dependence, procedural complexity, and potential complications. Artificial intelligence (AI) has emerged as a promising adjunct to address these limitations by enhancing diagnostic accuracy and optimizing procedural workflows.
Areas covered: This review comprehensively examines the application of AI across diverse clinical practices in digestive endoscopy. Key areas include lesion detection and diagnosis, lesion characterization and classification, quality control, workflow optimization, and therapeutic guidance. Additionally, it highlights the principal AI technologies that have received regulatory approval from the Food and Drug Administration (FDA) and European CE marking, underscoring their clinical readiness and integration potential.
Expert opinion: AI demonstrates significant potential to improve endoscopic outcomes by augmenting lesion detection rates and diagnostic precision. However, the translation of AI innovations into routine clinical practice is tempered by challenges, such as variability in clinical effectiveness, dependency on procedural quality, domain generalizability, and cost-effectiveness considerations. Future advancements should focus on enhancing AI robustness, integrating multimodal data, and establishing sustainable implementation frameworks to maximize clinical benefit while maintaining patient safety and ethical standards.
期刊介绍:
The enormous health and economic burden of gastrointestinal disease worldwide warrants a sharp focus on the etiology, epidemiology, prevention, diagnosis, treatment and development of new therapies. By the end of the last century we had seen enormous advances, both in technologies to visualize disease and in curative therapies in areas such as gastric ulcer, with the advent first of the H2-antagonists and then the proton pump inhibitors - clear examples of how advances in medicine can massively benefit the patient. Nevertheless, specialists face ongoing challenges from a wide array of diseases of diverse etiology.